Background To determine clinical-pathologic variables in patients with a new diagnosis of hepatocellular carcinoma (HCC) and underlying hepatitis B vs. C infection. Methods Patients presenting to ...

Background: Hepatoblastoma (HBL) and hepatocellular carcinoma (HCC ... positive epatitis-B-surface-antigen (HBV), alpha-fetoprotein increase, and echo features including septa, calcification ...

Objective: To investigate the probability of hepatocellular carcinoma (HCC) in a large number of gray-zone (GZ) patients with chronic hepatitis B (CHB) in clinical practice. Methods: The patients with ...

OBJECTIVE: Despite the availability of treatment and vaccines for chronic hepatitis B infection, it remains a public health problem. The use of nucleos(t)ide antiviral agents is effective in ...

导读丁型肝炎病毒（hepatitis D virus，HDV）感染可导致严重形式的慢性病毒性肝炎，但其对乙型肝炎病毒（hepatitis B virus，HBV）肝硬化患者发生肝细胞癌（Hepatocellular ...

Hepatocellular carcinoma (HCC) accounts for approximately 80% of all cases of primary liver cancer, the third leading cause of cancer mortality worldwide. In this Review, the authors discuss ...

Hepatitis B virus (HBV) infection contributes to hepatocellular carcinoma (HCC) tumorigenesis, drug resistance, and recurrence, although the underlying molecular mechanisms remain unclear.

This study found that HBV increases sorafenib and regorafenib resistance in HCCs through upregulation of CD133 and activation of the SRC/STAT3 signaling pathway. Our data provide a potentially key ...

During a Case-Based Roundtable® event, Pierre Gholam, MD, discussed how post hoc and real-world analyses build upon the ...

Hepatitis, particularly types B and C, has a profound impact on liver health, often leading to serious conditions like cirrhosis and liver cancer. These viral infections initiate an inflammatory ...